Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$0.24 - $0.52 $904 - $1,959
-3,768 Reduced 87.55%
536 $0
Q4 2022

Feb 09, 2023

SELL
$0.22 - $1.04 $7,009 - $33,134
-31,860 Reduced 88.1%
4,304 $1,000
Q3 2022

Nov 10, 2022

SELL
$0.25 - $2.4 $2,127 - $20,421
-8,509 Reduced 19.05%
36,164 $32,000
Q2 2022

Aug 10, 2022

SELL
$1.22 - $3.05 $38,878 - $97,197
-31,868 Reduced 41.64%
44,673 $56,000
Q1 2022

May 12, 2022

BUY
$2.64 - $4.67 $66,623 - $117,852
25,236 Added 49.19%
76,541 $235,000
Q4 2021

Feb 10, 2022

BUY
$4.4 - $8.8 $179,770 - $359,541
40,857 Added 391.05%
51,305 $229,000
Q3 2021

Nov 10, 2021

BUY
$7.44 - $13.99 $77,733 - $146,167
10,448 New
10,448 $79,000

Others Institutions Holding SMFR

About Sema4 Holdings Corp.


  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.